Halagon (halofuginone lactate) - QP51AX08
Updated on site: 09-Feb-2018
This is a summary of the European public assessment report (EPAR) for Halagon. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Halagon.
For practical information about using Halagon, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
What is Halagon and what is it used for?
Halagon is a medicine used to treat newborn calves to prevent or reduce diarrhoea caused by an organism called Cryptosporidium parvum. This is a parasite belonging to the ‘protozoa’ family that invades the digestive system, causing diarrhoea. The infection is known as cryptosporidiosis.
The medicine contains the active substance halofuginone.
Halagon is a ‘generic medicine’. This means that Halagon is similar to a ‘reference medicine’ already authorised in the EU called Halocur.
How is Halagon used?